Absence of PRKAG2 Mutation in Isolated Familial Wolff-Parkinson-White Syndrome A Case Report

نویسندگان

  • Chia-Sung Wang
  • Chia-Ti Tsai
  • Yen-Hong Lin
  • Kuan-Lih Hsu
  • Chuen-Den Tseng
  • Jiunn-Lee Lin
  • Yi-Lwun Ho
چکیده

Familial Wolff-Parkinson-White (WPW) syndrome has an autosomal dominant inheritance. Previous genetic linkage studies showed the locus was on Chromosome 7 (7q3), and the gene was identified to be PRKAG2, which encodes for gamma-2 subunit of AMP-activated protein kinase (AMPK). The PRKAG2 mutation has been related to familial WPW syndrome with concomitant hypertrophic cardiomyopathy and/or atrio-ventricular nodal disease. There was no data about PRKAG2 mutation and familial WPW syndrome in Taiwan. Therefore, we report the status of PRKAG2 mutation in a family containing 2 siblings with documented WPW syndrome. Neither cardiac hypertrophy nor atrio-ventricular nodal disease was found in this family. Polymerase chain reactions were performed to amplify the translated region of the PRKAG2 gene. Denaturing high-performance liquid chromatography was subsequently used to screen for the presence of heterodulplexes, and DNA sequencing was applied to these heterodulplexes. No PRKAG2 mutation was identified in these family members, although four intronic single nucleotide polymorphisms (SNPs) were identified (in introns 2, 5, 9, and 16 respectively). In conclusion, this case report shows the absence of association between PRKAG2 mutation and isolated familial WPW syndrome (without concomitant hypertrophic cardiomyopathy and/or atrio-ventricular nodal disease).

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy.

BACKGROUND We recently reported a mutation in the PRKAG2 gene to be responsible for a familial syndrome of ventricular preexcitation, atrial fibrillation, conduction defects, and cardiac hypertrophy. We now report a novel mutation in PRKAG2 causing Wolff-Parkinson-White syndrome and conduction system disease with onset in childhood and the absence of cardiac hypertrophy. METHODS AND RESULTS D...

متن کامل

Left ventricular noncompaction associated with hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome

We report a 35-year-old female patient with hypertrophic cardiomyopathy, left ventricular noncompaction, and Wolff-Parkinson-White EKG pattern. Several other family members present the same clinical condition. We speculate that this phenotype is related to the genotypes PRKAG2 and LAMP2 represented by mutations of the genes encoding AMP-activated protein kinase (PRKAG2) and lysosome associated ...

متن کامل

Overexpression of G100S mutation in PRKAG2 causes Wolff-Parkinson-White syndrome in zebrafish.

The Wolff-Parkinson-White (WPW) syndrome was believed to be associated with PRKAG2 gene mutations. In this study, we verified the pathopoiesis of G100S mutation, a novel mutation only discovered in Chinese patients with WPW, in cardiac disorder. Similar to R302Q, when overexpressed PRKAG2 G100S mutant in zebrafish, we observed a thicker heart wall, detected a decreased AMPK enzymatic activity b...

متن کامل

Wolff-Parkinson-White Syndrome with Ventricular Hypertrophy in a Brazilian Family

BACKGROUND PRKAG2 syndrome diagnosis is already well-defined as Wolff-Parkinson-White syndrome (WPW), ventricular hypertrophy (VH) due to glycogen accumulation, and conduction system disease (CSD). Because of its rarity, there is a lack of literature focused on the treatment. The present study aimed to describe appropriate strategies for the treatment of affected family members with PRKAG2 synd...

متن کامل

Radiofrequency catheter ablation in the treatment of Wolff-Parkinson-White syndrome

Introduction: Tachyarrhythmias in Wolf Parkinson White (WPW) syndrome, can be a life threatening factor. Antiarrhythmic drug therapy in this syndrome, has not been completely acceptable. Efficacy, safety and economy of Radio Frequency Catheter Ablation (RFCA) in western studies, has made it as the treatment of choice. In the present study, efficacy of RFCA in the ablation of accessory pathway...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2006